Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0001511 (
Adhesion
)
5,955
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Brucellosis
remains a major zoonosis worldwide; therefore, better understanding of its immunology is a priority for the development of new therapeutic and vaccination strategies. Genetic factors appear to have an important role in the pathogenesis of infectious diseases such as
brucellosis
.
Adhesion
molecules, such as members of the selectin family, participate in the interaction between leukocytes and the endothelium, as well as in inflammatory cell recruitment. The impact of L-selectin polymorphisms on
brucellosis
has not so far been investigated. The aim of this study was to assess an L-selectin Phe206Leu (F206L) polymorphism in patients with active
brucellosis
, and to analyse its possible relationship with disease progression. A case-control association study was carried out on 619 subjects, including 374 patients with
brucellosis
and 245 age- and sex-matched healthy controls. Genomic DNA was isolated, and amplification of L-selectin genomic regions was performed by PCR incorporating sequence-specific primers (PCR-SSP) to distinguish the genotypes. The frequencies of the F206L polymorphism were studied. A significant difference in F206L polymorphism was found between patients with
brucellosis
and controls. The 206Leu allele was more frequent in patients than in healthy individuals (36.6 versus 28 %, P=0.003). In addition, there was an association between the presence of the 206Leu allele and a relapse of
brucellosis
(odds ratio 6.53, 95 % confidence interval 1.5-28.8, P=0.005). The higher frequency of L-selectin genotypes in patients with
brucellosis
than in control individuals, as well as the association between the 206Leu allele and the occurrence of
brucellosis
relapse, suggest that the F206L polymorphism could make individuals more vulnerable to
brucellosis
.
...
PMID:Association between the Phe206Leu polymorphism of L-selectin and brucellosis. 1658 36
A central aspect of
Brucella
pathogenicity is its ability to invade, survive, and replicate in diverse phagocytic and non-phagocytic cell types, leading to chronic infections and chronic inflammatory phenomena.
Adhesion
to the target cell is a critical first step in the invasion process. Several
Brucella
adhesins have been shown to mediate adhesion to cells, extracellular matrix components (ECM), or both. These include the sialic acid-binding proteins SP29 and SP41 (binding to erythrocytes and epithelial cells, respectively), the BigA and BigB proteins that contain an Ig-like domain (binding to cell adhesion molecules in epithelial cells), the monomeric autotransporters BmaA, BmaB, and BmaC (binding to ECM components, epithelial cells, osteoblasts, synoviocytes, and trophoblasts), the trimeric autotransporters BtaE and BtaF (binding to ECM components and epithelial cells) and Bp26 (binding to ECM components). An in vivo role has also been shown for the trimeric autotransporters, as deletion mutants display decreased colonization after oral and/or respiratory infection in mice, and it has also been suggested for BigA and BigB. Several adhesins have shown unipolar localization, suggesting that
Brucella
would express an adhesive pole. Adhesin-based vaccines may be useful to prevent
brucellosis
, as intranasal immunization in mice with BtaF conferred high levels of protection against oral challenge with
B. suis
.
...
PMID:Adhesins of
Brucella
: Their Roles in the Interaction with the Host. 3319 23